통합암치료를 적용한 폐전이 동반 췌장암 환자의 장기간 추적관찰 증례보고
Long-Term Follow-up of Pancreatic Cancer Patients with Lung Metastasis Using Integrated Cancer Treatment: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: This long-term case report details a case of pancreatic cancer with lung metastasis suppressed by integrative cancer medicine (IMT). Methods: A 64-year-old woman diagnosed with pancreatic cancer visited a Korean medicine hospital complaining about the side effects of chemotherapy for lung metastasis. She received IMT involving Korean traditional medicine and Western immunotherapy from May 2017 to June 2023. Tumor dimensions were assessed through computed tomography (CT) and positron-emission tomography/CT scans, while tumor markers and safety were monitored by laboratory tests. Results: IMT suppressed the progression of cancer, as observed by imaging and laboratory tests. The patient achieved 5-year survival, even after discontinuing chemotherapy. Conclusion: This case presents a potential therapeutic alternative for patients who are ineligible for chemotherapy or surgical interventions.
Abstract
Objective: This long-term case report details a case of pancreatic cancer with lung metastasis suppressed by integrative cancer medicine (IMT). Methods: A 64-year-old woman diagnosed with pancreatic cancer visited a Korean medicine hospital complaining about the side effects of chemotherapy for lung metastasis. She received IMT involving Korean traditional medicine and Western immunotherapy from May 2017 to June 2023. Tumor dimensions were assessed through computed tomography (CT) and positron-emission tomography/CT scans, while tumor markers and safety were monitored by laboratory tests. Results: IMT suppressed the progression of cancer, as observed by imaging and laboratory tests. The patient achieved 5-year survival, even after discontinuing chemotherapy. Conclusion: This case presents a potential therapeutic alternative for patients who are ineligible for chemotherapy or surgical interventions.
참고문헌 (18)
- "Cancer Stat Facts: Pancreatic Cancer"[URL]
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2022", Cancer Research and Treatment, 54(2), pp.345~351 (2022), 대한암학회[DOI]
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
- Committee of the Korean clinical practice guideline for pancreatic cancer and National Cancer Center, "Korea. Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches", Pancreatology, 21(7), pp.1326~1341 (2021)
- Conroy T, "FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer", N Engl J Med, 364(19), pp.1817~1825 (2011)
- Von Hoff DD, "Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine", N Engl J Med, 369(18), pp.1691~1703 (2013)
- 한가진, "췌장암에 대한 국내 한의학 연구 동향 고찰 - 국내 한의학 논문을 중심으로 -", 대한한방내과학회지, 40(1), pp.70~88 (2019), 대한한방내과학회[DOI]
- 고은비, "항암화학요법과 통합의학치료를 병행하여 부분 관해 된 간전이 동반 말기 췌장암 1례", 대한한방내과학회지, 41(2), pp.166~176 (2020), 대한한방내과학회[DOI]
- 방선휘, "림프절 전이를 동반한 췌장암환자 1례에 대한 보고", 대한한방내과학회지, 28(4), pp.948~955 (2007), 대한한방내과학회
- 김재욱, "재발된 췌장암 환자의 한의 기반 통합 암 치료에 대한 증례보고", 대한암한의학회지, 27(1), pp.1~12 (2022), 대한암한의학회
- Mizrahi JD, "Pancreatic cancer", Lancet, 395(10242), pp.2008~2020 (2020)
- 윤해창, "암 환자에 대한 구법의 치료와 메커니즘에 대한 최신 국내외 연구 현황", 대한한방내과학회지, 36(3), pp.361~379 (2015), 대한한방내과학회
- Guo JQ, "Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin", EphA2, MMP2 expression, pp.Int J Oncol, 2014[DOI]
- 방지영, "Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B), a Korean traditional medicine, using antibody microarray chip", BioChip Journal, 4(4), pp.350~355 (2010), 한국바이오칩학회
- Kim JM, "Case Report of the Pancreatic Cancer Patient after Pancreatoduodenectomy who is Taking the HangAm-Plus to Anti-metastasis and Preventing Recurrence", J of Kor Traditional Oncology, 16(1), pp.33~39 (2011)
- Böttger F, "High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer", J Exp Clin Cancer Res, 40(1), pp.343~ (2021)
- Thronicke A, "Viscum album L. Therapy in Oncology:An Update on Current Evidence", Complement Med Res, 29(4), pp.362~368 (2022)
- Wei Y, "Thymosin α-1 in cancer therapy : Immunoregulation and potential applications", Int Immunopharmacol, 117, pp.109744~ (2023)